Krishna Institute of Medical Sciences Future Growth
Future criteria checks 2/6
Krishna Institute of Medical Sciences is forecast to grow earnings and revenue by 15.4% and 14.9% per annum respectively. EPS is expected to grow by 15.2% per annum. Return on equity is forecast to be 15.6% in 3 years.
Key information
15.4%
Earnings growth rate
15.2%
EPS growth rate
Healthcare earnings growth | 27.0% |
Revenue growth rate | 14.9% |
Future return on equity | 15.6% |
Analyst coverage | Good |
Last updated | 19 Mar 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
3/31/2026 | 35,061 | 4,805 | 2,196 | N/A | 10 |
3/31/2025 | 29,555 | 4,041 | 292 | N/A | 11 |
3/31/2024 | 25,260 | 3,360 | -1,773 | N/A | 9 |
12/31/2023 | 24,403 | 3,379 | N/A | N/A | N/A |
9/30/2023 | 23,966 | 3,421 | -2,263 | 4,621 | N/A |
6/30/2023 | 23,082 | 3,472 | N/A | N/A | N/A |
3/31/2023 | 21,977 | 3,363 | -1,424 | 4,321 | N/A |
12/31/2022 | 19,941 | 3,237 | N/A | N/A | N/A |
9/30/2022 | 18,255 | 3,289 | 741 | 3,693 | N/A |
6/30/2022 | 16,732 | 3,135 | N/A | N/A | N/A |
3/31/2022 | 16,508 | 3,327 | 1,537 | 3,240 | N/A |
12/31/2021 | 16,370 | 3,098 | N/A | N/A | N/A |
9/30/2021 | 16,041 | 2,774 | 2,318 | 3,488 | N/A |
6/30/2021 | 16,020 | 2,792 | N/A | N/A | N/A |
3/31/2021 | 13,299 | 2,012 | 2,615 | 3,560 | N/A |
12/31/2020 | 12,412 | 1,721 | 3,180 | 3,774 | N/A |
3/31/2020 | 11,227 | 1,192 | 1,495 | 2,015 | N/A |
3/31/2019 | 9,204 | -477 | 566 | 1,339 | N/A |
3/31/2018 | 6,652 | -474 | 473 | 1,058 | N/A |
3/31/2017 | 5,689 | 326 | N/A | 815 | N/A |
3/31/2016 | 5,145 | 266 | N/A | 955 | N/A |
3/31/2015 | 4,222 | 56 | N/A | 639 | N/A |
3/31/2014 | 3,569 | 69 | N/A | 778 | N/A |
3/31/2013 | 2,943 | 189 | N/A | 346 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 543308's forecast earnings growth (15.4% per year) is above the savings rate (6.7%).
Earnings vs Market: 543308's earnings (15.4% per year) are forecast to grow slower than the Indian market (17.8% per year).
High Growth Earnings: 543308's earnings are forecast to grow, but not significantly.
Revenue vs Market: 543308's revenue (14.9% per year) is forecast to grow faster than the Indian market (10.5% per year).
High Growth Revenue: 543308's revenue (14.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 543308's Return on Equity is forecast to be low in 3 years time (15.6%).